As an Associate Partner in L2 Consulting, Dr. John S. Sampalis M.SC., PHD., FACE, FAHA is also founder and CEO of JSS Medical Research (founded in 1997).

He is a tenured professor of Surgery and Medicine at McGill University and the University of Montreal. Throughout his career, he has received numerous scholarships from provincial and federal funding agencies, including the Medical Research Council of Canada, the National Health Development Program, and the Fonds de la recherche en
santé du Quebec. With over 200 peer-reviewed publications in high ranking journals and more than 15 million dollars in research funding, Dr. Sampalis is recognized as one of the
top clinical epidemiologists in the world with extensive expertise in clinical trials, health services research, health economics, and outcome assessment as well as biostatistics. He has assisted several biotech and pharmaceutical companies in developing innovative and efficient solutions for product development, including the use of adaptive designs and synthetic control trials.

He has also been a leader in Real World Evidence, making significant contributions to the methodology and directly applying Real-World Studies to change healthcare practices and policies. His current methodological initiatives are in line with the current developments and evolution of evidence-based medicine, which calls for the integration of RWE with traditional clinical trials.

He has served as a consultant for numerous pharmaceutical companies, hospitals and government organizations and agencies.

Dr. Sampalis is currently a Fellow of the American College of Epidemiology and of the American Heart Association.

John Sampalis​ B.Sc., B.A.(Hon), M.Sc., Ph.D., F.A.C.E, F.A.H.A